Center for Scientific Review; Notice of Closed Meetings, 929-930 [2020-00109]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 5 / Wednesday, January 8, 2020 / Notices
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/nhlbac/
index.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: January 2, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–00067 Filed 1–7–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neurodifferentiation,
Plasticity, Regeneration and Rhythmicity
Study Section.
Date: February 4–5, 2020.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:18 Jan 07, 2020
Jkt 250001
Place: Embassy Suites Alexandria Old
Town, 1900 Diagonal Road, Alexandria, VA
22314.
Contact Person: Joanne T. Fujii, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4184,
MSC 7850, Bethesda, MD 20892, (301) 435–
1178, fujiij@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Musculoskeletal Tissue Engineering Study
Section.
Date: February 5–6, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Virginian Suites, 1500 Arlington
Boulevard, Arlington, VA 22209.
Contact Person: Baljit S. Moonga, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7806, Bethesda, MD 20892, 301–435–
1777, moongabs@mail.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Molecular
Genetics B Study Section.
Date: February 5, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Four Points Los Angeles Westside,
5990 Green Valley Circle, Culver City, CA
90230.
Contact Person: Emily Foley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2206,
Bethesda, MD 20892, (301) 435–0627,
emily.foley@nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Tumor Cell Biology Study Section.
Date: February 6–7, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin St. Francis, 335 Powell
Street, San Francisco, CA 94102.
Contact Person: Charles Morrow, M.D.,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, 301–408–
9850, morrowcs@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Intercellular
Interactions Study Section.
Date: February 6, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Thomas Y. Cho, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301–402–4179,
thomas.cho@nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Cellular and Molecular
Biology of Glia Study Section.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
929
Date: February 6–7, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel & Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Linda MacArthur, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4187,
Bethesda, MD 20892, 301–537–9986,
macarthurlh@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Transplantation,
Tolerance, and Tumor Immunology Study
Section.
Date: February 6–7, 2020.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Kabuki, 1625 Post Street, San
Francisco, CA 94115.
Contact Person: Jin Huang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4199,
MSC 7812, Bethesda, MD 20892, 301–435–
1230, jh377p@nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Biobehavioral Regulation, Learning
and Ethology Study Section.
Date: February 6, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, 1 Bethesda
Metro Center, 7400 Wisconsin Ave.,
Bethesda, MD 20814.
Contact Person: Unja Hayes, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda 20892, 301–827–
6830, unja.hayes@nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Skeletal Muscle and Exercise Physiology
Study Section.
Date: February 6–7, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Long Beach and Executive
Center, 701 West Ocean Boulevard, Long
Beach, CA 90831.
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, 301–496–
8551, ingrahamrh@mail.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group;
Therapeutic Approaches to Genetic Diseases
Study Section.
Date: February 6–7, 2020.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Methode Bacanamwo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
E:\FR\FM\08JAN1.SGM
08JAN1
930
Federal Register / Vol. 85, No. 5 / Wednesday, January 8, 2020 / Notices
[FR Doc. 2020–00112 Filed 1–7–20; 8:45 am]
Dated: January 3, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
Coast Guard
[FR Doc. 2020–00109 Filed 1–7–20; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Coast Guard, DHS.
Notice of intent to prepare an
EIS; and request for comments.
In accordance with the
National Environmental Policy Act of
1969 (NEPA) and the regulations
implemented by the Council on
Environmental Quality (CEQ), and the
National Historic Preservation Act
(NHPA), the Coast Guard announces its
intent to prepare an Environmental
Impact Statement (EIS) to evaluate the
potential environmental consequences
of replacing the existing BNSF bridge
across the Missouri River at Bismarck,
ND, or constructing a bridge adjacent to
the existing bridge. CEQ regulations
require an early and open process for
determining the scope of issues that the
Coast Guard needs to address in an EIS
(‘‘scoping’’). Scoping determines which
issues to analyze in depth in the EIS and
eliminates from detailed study the
issues that are not significant or were
covered in prior environmental reviews.
This document invites the participation
of affected federal, state, and local
agencies, any affected Indian tribes and
other interested persons in determining
the appropriate issues for EIS analysis
for this project.
DATES: Comments must be submitted to
the online docket via https://
www.regulations.gov/, on or before
February 24, 2020.
ADDRESSES: You may submit comments
identified by docket number USCG–
2019–0882 using the Federal
eRulemaking Portal at https://
www.regulations.gov/. See the ‘‘Public
Participation and Request for
Comments’’ portion of the
SUPPLEMENTARY INFORMATION section for
further instructions on submitting
comments.
FOR FURTHER INFORMATION CONTACT: Rob
McCaskey, Coast Guard District Eight
Project Officer, 314–269–2381.
SUMMARY:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; SBIR Phase I.
Date: February 4, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, DEM1,
6701 Democracy Blvd., Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Rahat (Rani) Khan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, 6701 Democracy
Blvd., Rm. 1078, Bethesda, MD 20892, 301–
594–7319, khanr2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Jkt 250001
[Docket Number USCG–2019–0882]
ACTION:
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
17:18 Jan 07, 2020
DEPARTMENT OF HOMELAND
SECURITY
AGENCY:
National Institutes of Health
VerDate Sep<11>2014
BILLING CODE 4140–01–P
BNSF Railway Bridge Across the
Missouri River at Bismarck, North
Dakota; Preparation of Environmental
Impact Statement
BILLING CODE 4140–01–P
jbell on DSKJLSW7X2PROD with NOTICES
Dated: January 3, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
Health, 6701 Rockledge Drive, Room 2200,
Bethesda, MD 20892, 301–827–7088,
methode.bacanamwo@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
SUPPLEMENTARY INFORMATION:
I. Background and Purpose
BNSF Railway Company owns and
operates the existing bridge that crosses
the Missouri River between the cities of
Mandan, and Bismarck, North Dakota.
With components over 130 years old,
the in-place structure is approaching the
end of its useful service life. The
structure has a history of exposure to ice
jams and its substructure configuration
renders it potentially susceptible to
scour events. Although currently stable,
the structure has experienced structural
issues at both approaches in the past,
resulting in unanticipated substructure
movements. Since constructing the
original bridge in 1882, the east hill
slope began to move and resulted in the
slope moving the pier west towards the
river inches per year. Multiple
remediation efforts to correct the pier
damage/location and slope movement
took place from the early 1800s to the
mid 1950s. The intent of the project is
to construct a new, independent bridge
across the Missouri River upstream of
the in-place structure. Operationally,
the new structure will carry the
mainline track and the current structure
will be taken down. The new structure
will provide a significant improvement
in operational reliability and safety, and
will provide enhanced structural
redundancy thereby making it less
susceptible to damage. As the current
structure is 130 years old, it requires
substantial inspection and maintenance,
which are disruptive to rail service. The
new structure will be a single-track
bridge but have the capability to carry
a second track in the future when and
if volumes necessitate that addition.
The BNSF Bismarck Bridge was
constructed with similar methods in the
same era as the Brooklyn Bridge. It is an
iconic landmark that predates official
North Dakota statehood by six years.
The bridge is eligible for listing in the
National Register of Historic Places for
its association with broad patterns of
railroad, commercial and military
history of the United States. Because of
these attributes, certain interest groups
have expressed a desire to preserve the
existing bridge.
The federal bridge statutes, including
the River and Harbors Act of 1899, as
amended, the Act of March 23, 1906, as
amended, and the General Bridge Act of
1946 (33 U.S.C. 525 et seq.), require that
the location and plans of bridges in or
over navigable waters of the United
States be approved by the Secretary of
Homeland Security, who has delegated
that responsibility to the Coast Guard.
The Missouri River is a navigable water
of the United States as defined in 33
E:\FR\FM\08JAN1.SGM
08JAN1
]]>Agencies
[Federal Register Volume 85, Number 5 (Wednesday, January 8, 2020)]
[Notices]
[Pages 929-930]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00109]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Neurodifferentiation,
Plasticity, Regeneration and Rhythmicity Study Section.
Date: February 4-5, 2020.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Alexandria Old Town, 1900 Diagonal Road,
Alexandria, VA 22314.
Contact Person: Joanne T. Fujii, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4184, MSC 7850, Bethesda, MD
20892, (301) 435-1178, [email protected].
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group; Musculoskeletal Tissue Engineering Study
Section.
Date: February 5-6, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Virginian Suites, 1500 Arlington Boulevard, Arlington, VA
22209.
Contact Person: Baljit S. Moonga, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214, MSC 7806, Bethesda, MD
20892, 301-435-1777, [email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Molecular Genetics B Study Section.
Date: February 5, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Four Points Los Angeles Westside, 5990 Green Valley
Circle, Culver City, CA 90230.
Contact Person: Emily Foley, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2206, Bethesda, MD 20892, (301) 435-0627,
[email protected].
Name of Committee: Oncology 1--Basic Translational Integrated
Review Group; Tumor Cell Biology Study Section.
Date: February 6-7, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Westin St. Francis, 335 Powell Street, San Francisco,
CA 94102.
Contact Person: Charles Morrow, M.D., Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202, MSC 7804, Bethesda, MD
20892, 301-408-9850, [email protected].
Name of Committee: Cell Biology Integrated Review Group;
Intercellular Interactions Study Section.
Date: February 6, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Thomas Y. Cho, Ph.D., Scientific Review Officer,
Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD
20892, 301-402-4179, [email protected].
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Cellular and Molecular Biology
of Glia Study Section.
Date: February 6-7, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Lorien Hotel & Spa, 1600 King Street, Alexandria, VA
22314.
Contact Person: Linda MacArthur, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4187, Bethesda, MD 20892, 301-
537-9986, [email protected].
Name of Committee: Immunology Integrated Review Group;
Transplantation, Tolerance, and Tumor Immunology Study Section.
Date: February 6-7, 2020.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Kabuki, 1625 Post Street, San Francisco, CA 94115.
Contact Person: Jin Huang, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4199, MSC 7812, Bethesda, MD 20892, 301-435-
1230, [email protected].
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Biobehavioral Regulation, Learning and
Ethology Study Section.
Date: February 6, 2020.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, 1 Bethesda Metro Center, 7400
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Unja Hayes, Ph.D., Scientific Review Officer,
National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda 20892, 301-827-6830, [email protected].
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group; Skeletal Muscle and Exercise Physiology
Study Section.
Date: February 6-7, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Long Beach and Executive Center, 701 West Ocean
Boulevard, Long Beach, CA 90831.
Contact Person: Richard Ingraham, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116, MSC 7814, Bethesda, MD
20892, 301-496-8551, [email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Therapeutic Approaches to Genetic Diseases Study
Section.
Date: February 6-7, 2020.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Methode Bacanamwo, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
[[Page 930]]
Health, 6701 Rockledge Drive, Room 2200, Bethesda, MD 20892, 301-
827-7088, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 3, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-00109 Filed 1-7-20; 8:45 am]
BILLING CODE 4140-01-P
